As of Jul 26
| -0.22 / -1.97%|
The 6 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 20.00, with a high estimate of 23.00 and a low estimate of 10.00. The median estimate represents a +82.65% increase from the last price of 10.95.
The current consensus among 6 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.